| Athena Resources Limited (AHN) ORDINARY FULLY PAID |
Materials |
$10 |
Excellent Narryer Drilling Results
|
12 Oct 2026 8:45AM |
$0.060 |
$0.062 |
risen by
3.33%
|
|
AHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Athena completed 31 RC holes for 2,266m and two PQ diamond drill holes for 115.4m at the Narryer Prospect.
- Narryer Main returned four broad magnetite intersections of 40m or more, including 44m at 31.79% Fe in AHRC0151.
- Maiden drilling at Narryer Southwest confirmed new mineralisation with 31m at 32.74% Fe from 55m in hole AHRC0131.
- Narryer Southwest is approximately 6km from Narryer Main and has about 1.8km of combined strike length that remains largely untested.
- Davis Tube Recovery test work at a 150µm grind produced a weighted average concentrate grade of 67.44% Fe with 33.48% mass recovery for Narryer Main.
- Narryer Southwest DTR results produced a concentrate grade of 69.70% Fe with 40.38% mass recovery.
- The drilling improved understanding of magnetite-bearing lithologies, geometry and structural controls, with sigmoidal magnetite bodies interpreted at Narryer.
- Athena has commenced work on a maiden Narryer Mineral Resource Estimate targeted for completion in December 2026.
- Narryer is part of Athena’s 100%-owned Byro Magnetite Project in Western Australia’s Midwest Iron province.
- The company sees the new geological data as strengthening the basis for assessing the potential economics of Narryer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,482 |
Notice of Annual General Meeting and Proxy Form
|
12 Oct 2026 8:43AM |
$17.150 |
$14.400 |
fallen by
16.03%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$652 |
Net Tangible Asset Backing
|
12 Oct 2026 8:42AM |
$2.020 |
$2.020 |
fallen by
0%
|
|
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$33 |
Cleansing Notice
|
12 Oct 2026 8:42AM |
$0.094 |
$0.090 |
fallen by
4.26%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,482 |
Application for quotation of securities - SRL
|
12 Oct 2026 8:39AM |
$17.150 |
$14.400 |
fallen by
16.03%
|
|
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$13 |
Drilling Commences at Oonagalabi Copper-Zinc Project
|
12 Oct 2026 8:39AM |
$0.225 |
$0.200 |
fallen by
11.11%
|
|
| Altitude Minerals Ltd (ATT) ORDINARY FULLY PAID |
Materials |
$2 |
Altitude Minerals Quarterly Activities and Cashflow Report
|
12 Oct 2026 8:39AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
ATT - Price-sensitive ASX Announcement
Full Release
Key Points
- Report date is 12 October 2026 for the quarter ended 30 September 2026.
- Altitude Minerals focused on advancing its Nevada silver and gold projects and reviewing new Nevada opportunities.
- The 100%-owned Firenze Project is drill-ready for a 2,100m RC program after completion of access, pads, earthworks and regulatory requirements.
- Firenze targeting was supported by CSAMT and magnetic surveys, structural and alteration mapping, and a 3D geological model.
- Firenze historical rock chips returned up to 1,825 g/t silver and 44 g/t gold, with the key target interpreted at about 100m to 250m depth.
- At the W-Project, Altitude expanded its ground position by staking 15 additional claims, increasing the land package to 48 claims.
- W-Project validation included CSAMT and magnetic surveys, mapping and sampling, with the aim of making it drill-ready for a combined program with Firenze.
- Historical drilling at W showed 40 of 43 holes intersected gold mineralisation and 7 holes ended in mineralisation.
- Notable historical W-Project results included 37m at 1.30 g/t Au and 9.8 g/t Ag from 31m, 3m at 3.75 g/t Au and 4.2 g/t Ag from 73m, and 3m at 1.6 g/t Au and 22 g/t Ag from 81m.
- At the Byrock Project in NSW, Altitude completed 1,501m of drilling across five holes testing three priority pipe-like porphyry copper-gold targets.
- Byrock drilling confirmed pipe-like structures and deep crustal-tapping features but assays were disappointing, with no significant copper mineralisation and only minor gold.
- Altitude withdrew from the Byrock earn-in and JV with Nimrod Resources and plans to relinquish associated tenements.
- The remaining Australian Theseus Project is intended to be advanced through a non-dilutive mechanism or divested.
- Dr Paul Kitto was appointed as a Non-Executive Director in September 2026.
- The company completed a two-tranche placement raising $1.215 million at $0.005 per share and launched an entitlement offer targeting up to a further $1.487 million.
- Placement and entitlement offer proceeds are intended for drilling at Firenze and the W/Winnemucca project area, business development and working capital.
- Cash at 30 September 2026 was $817,000.
- Net cash used in operating activities for the quarter was $551,000.
- Exploration expenditure during the quarter was $315,000.
- Related party payments for the quarter totalled $120,000.
- The company disclosed estimated funding for about 1.5 quarters based on current outflows, with expected support from an $880,000 second placement tranche and the open entitlement offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$33 |
Application for quotation of securities - OD6
|
12 Oct 2026 8:37AM |
$0.094 |
$0.090 |
fallen by
4.26%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,752 |
Notice of Annual General Meeting/Proxy Form
|
12 Oct 2026 8:36AM |
$2.450 |
$1.780 |
fallen by
27.35%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$8 |
Proposed issue of securities - FRE
|
12 Oct 2026 8:36AM |
$0.029 |
$0.028 |
fallen by
3.45%
|
|
| Osmond Resources Limited (OSM) ORDINARY FULLY PAID |
Materials |
$118 |
Osmond Confirms Arrival of Second Drill Rig
|
12 Oct 2026 8:35AM |
$0.600 |
$0.525 |
fallen by
12.50%
|
|
OSM - Price-sensitive ASX Announcement
Full Release
Key Points
- Osmond confirmed the arrival of a second drill rig at the Orión EU Critical Minerals Project.
- Two drill rigs were expected to be operational during the week commencing 12 October 2026.
- The first drill hole, SOR-08B, had reached 158 metres and was targeting stratigraphy at about 210 metres below surface.
- The original 13-hole drilling program was expanded with additional infill drilling to a total of 15 to 20 holes.
- The drilling program is aimed at expanding the Mineral Resource Estimate and increasing confidence levels.
- Osmond is targeting an upgraded MRE and updated Scoping Study in Q1 CY27, subject to drilling results.
- The upgraded MRE and updated Scoping Study are intended to support a mining licence application targeted for 1H CY27.
- Orión’s maiden JORC 2012 Mineral Resource Estimate was restated as 60.0 Mt at 9.39% TiO2, 3.06% ZrO2, 624 ppm HfO2 and 6,274 ppm TREO.
- The current MRE covers only about 3.4% of the Project’s approximately 232 km² tenure.
- Osmond holds an 80% interest in 95% of the Project, equating to a 76% beneficial interest.
- The earlier Scoping Study outlined a 2 Mtpa operation with an initial 9-year mine life and production of monazite, zircon and titanium concentrates.
- Near-term priorities also include a Spanish secondary listing, downstream product studies, and additional support applications in Andalucía and the EU.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Altitude Minerals Ltd (ATT) ORDINARY FULLY PAID |
Materials |
$2 |
Change of Registered Office Address
|
12 Oct 2026 8:35AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
| Computershare Limited (CPU) ORDINARY FULLY PAID |
Industrials |
$24,391 |
2026 Notice of AGM and Voting Form
|
12 Oct 2026 8:34AM |
$40.380 |
$42.170 |
risen by
4.43%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$10,043 |
Notification of cessation of securities - SGP
|
12 Oct 2026 8:34AM |
$4.280 |
$4.130 |
fallen by
3.50%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$10,043 |
Notification regarding unquoted securities - SGP
|
12 Oct 2026 8:32AM |
$4.280 |
$4.130 |
fallen by
3.50%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$123 |
Dimerix at Canaccord Drug & Device and Ignite Conferences
|
12 Oct 2026 8:32AM |
$0.220 |
$0.205 |
fallen by
6.82%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$8 |
Firebrick Secures $732k in Strategic Investments
|
12 Oct 2026 8:32AM |
$0.029 |
$0.028 |
fallen by
3.45%
|
|
FRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebrick Pharma secured approximately $732,000 in strategic investments via a placement of about 20.9 million shares at $0.035 per share.
- The placement was anchored by Philippine licensing partner Pharma Nutria N.A. Inc., which invested $631,750 and increased its holding to just over 10%.
- An existing sophisticated investor contributed the remaining $100,000.
- The placement follows Firebrick’s previously announced intention to enter the US retail pharmacy market for Nasodine products.
- The company will issue 18,050,000 shares under Listing Rule 7.1A and 2,857,142 shares under Listing Rule 7.1.
- The total shares to be issued represent approximately 7.28% of Firebrick’s current shares on issue.
- The issue price represented a 21.5% premium to the 15-day VWAP and a 20.7% premium to the last traded price on 9 October 2026.
- Placement proceeds will fund new production for US retail distribution, a new Nasodine product launch in Singapore, and working capital.
- Final issuance of shares was expected by 20 October 2026.
- No material costs or commissions were paid in connection with the placement.
- Firebrick said Nasodine Nasal Spray had already been introduced into several markets, was recently approved in Indonesia, and was expected to receive approval in the Philippines.
- Nasodine Throat Spray was available in Singapore and soon in the US, with Firebrick expanding in the US from online-only sales to pursuing retail pharmacy distribution.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,223 |
Update - Notification of buy-back - ABB
|
12 Oct 2026 8:32AM |
$4.150 |
$4.000 |
fallen by
3.61%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,840 |
Net Tangible Asset Backing
|
12 Oct 2026 8:31AM |
$4.520 |
$4.470 |
fallen by
1.11%
|
|
| Altitude Minerals Ltd (ATT) ORDINARY FULLY PAID |
Materials |
$2 |
Notice of 2026 AGM and Proxy Form
|
12 Oct 2026 8:31AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
| Xero Limited (XRO) ORDINARY FULLY PAID |
Information Technology |
$10,468 |
Xero appoints Mark Durcan to its Board of Directors
|
12 Oct 2026 8:28AM |
$59.810 |
$61.340 |
risen by
2.56%
|
|
| Core Lithium Ltd (CXO) ORDINARY FULLY PAID |
Materials |
$680 |
September Quarterly Report and Webcast
|
12 Oct 2026 8:26AM |
$0.245 |
$0.210 |
fallen by
14.29%
|
|
| Great Bear Exploration Ltd (GBL) ORDINARY FULLY PAID |
Energy |
$7 |
2026 Field Season Update
|
12 Oct 2026 8:26AM |
$0.019 |
$0.015 |
fallen by
21.05%
|
|
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$2,609 |
Update - Notification of buy-back - AUI
|
12 Oct 2026 8:26AM |
$11.830 |
$12.000 |
risen by
1.44%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$602 |
Cogstate 1Q27 Business Update
|
12 Oct 2026 8:25AM |
$3.450 |
$3.500 |
risen by
1.45%
|
|
CGS - Price-sensitive ASX Announcement
Full Release
Key Points
- Cogstate reported US$25.1 million in net sales contracts executed in 1Q27 for the quarter ended 30 September 2026.
- The result was supported by Cogstate’s strategy of combining scientific leadership in CNS endpoint quality with channel partnerships.
- More than 80% of quarterly contract sales value came from mood disorder work, including five Phase 3 trial wins in bipolar or depression across two customers.
- September quarter sales contracts were higher than the September quarter in FY26 at US$21.42 million and FY25 at US$11.40 million.
- Total contracted revenue at 30 September 2026 was US$143.7 million, up 41% from US$101.8 million in the previous corresponding period.
- Contracted revenue for 1H27 was US$31.7 million, up 38% from US$23.0 million.
- Contracted revenue for FY27 was US$56.8 million, up 45% from US$39.2 million in the previous corresponding period.
- Contracted revenue for FY28 to FY33 was US$86.9 million, up 39% from US$62.6 million.
- FY27 contracted revenue increased from US$48.3 million at 30 June 2026 to US$56.8 million at 30 September 2026.
- The US$25.1 million of new contracts signed in 1Q27 contributed US$8.4 million to FY27 contracted revenue, an in-year revenue yield of 34%.
- The lower-than-usual in-year yield reflected a licence fee contribution of 7%, below the historical average range of 20% to 25%, and a larger proportion of longer-duration Phase 3 trials.
- FY28 contracted revenue increased from US$31.4 million at 30 June 2026 to US$39.7 million at 30 September 2026, strengthening forward revenue coverage.
- Cogstate advised that its 2026 AGM would be held as a hybrid meeting at 10:00am AEDT on Thursday, 15 October 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
